The medtech spinout treating Parkinson’s disease with vibrations – Charco Neurotech co-founder Lucy Jung
Audio is streamed directly from the publisher (media.transistor.fm) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Lucy Jung, CEO and co-founder of Charco Neurotech, discusses spinning out a medical device startup from academia, the science behind treating Parkinson’s disease with vibrations, balancing regulation with innovation and how devices like Elon Musk’s Neuralink could “maximise our brain”.
Jung, who has a background in design, co-founded Charco Neurotech in 2019, launching out of Imperial College London. It has secured more than $10m in investment for its non-invasive, pebble-shaped device that delivers vibrotactile stimulation to the chest to improve motor performance and alleviate gait freezing for people with Parkinson’s. It can be linked with an accompanying smartphone app to track symptoms and customise treatment. The device is currently used by 900 people, with a further 12,000 on its waiting list.